$FMHS
FARMHOUSE, INC. /NV Stock $fmhs

$fmhs Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000109690622002757 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q4
Revenue	$2.640K	$4.974K	$200.00
YoY Change	1220.0%	3216.0%	-97.71%
Cost Of Revenue	$1.320K	$2.487K	$8.000K
YoY Change	-83.5%
Gross Profit	$1.320K	$2.487K	-$7.800K
YoY Change	-116.92%	1569.13%
Gross Profit Margin	50.0%	50.0%	-3900.0%
Selling, General & Admin	$141.1K	$176.9K	$339.7K
YoY Change	-58.47%	-28.75%	71.97%
% of Gross Profit	10690.15%	7114.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00	$300.00
YoY Change	-100.0%	-100.0%	0.0%
% of Gross Profit	0.0%	0.0%
Operating Expenses	$141.1K	$176.9K	$340.0K
YoY Change	-58.5%	-28.84%	151.71%
Operating Profit	-$139.8K	-$174.4K	-$347.8K
YoY Change	-59.81%	-29.8%
Interest Expense	$212.6K	$15.63K	-$9.530K
YoY Change	-2331.06%	-221.69%	-57.87%
% of Operating Profit
Other Income/Expense, Net	$0.00	$149.4K	$0.00
YoY Change		567.45%
Pretax Income	$72.58K	-$25.07K	-$357.4K
YoY Change	-120.31%	-88.84%	-38.11%
Income Tax
% Of Pretax Income
Net Earnings	$72.58K	-$25.07K	-$357.4K
YoY Change	-120.31%	-88.84%	-38.11%
Net Earnings / Revenue	2749.24%	-503.98%	-178685.0%
Basic Earnings Per Share
Diluted Earnings Per Share	$0.00	$0.00	-$22.66K
COMMON SHARES
Basic Shares Outstanding	17.05M shares	16.98M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$62.06K	$116.1K	$3.780K
YoY Change	1541.8%	158.08%	-3.32%
Cash & Equivalents	$62.06K	$116.1K	$3.780K
Short-Term Investments
Other Short-Term Assets	$3.810K	$7.620K	$3.750K
YoY Change	1.6%	1213.79%
Inventory
Prepaid Expenses	$3.810K	$7.620K	$3.750K
Receivables	$0.00	$4.974K	$0.00
Other Receivables		$0.00
Total Short-Term Assets	$65.87K	$128.7K	$7.530K
YoY Change	774.81%	182.44%	92.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$0.00	$0.00	$94.00
YoY Change	-100.0%	-100.0%	-92.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$250.00	$344.00
YoY Change	-100.0%	-37.5%	-72.91%
TOTAL ASSETS
Total Short-Term Assets	$65.87K	$128.7K	$7.530K
Total Long-Term Assets	$0.00	$250.00	$344.00
Total Assets	$65.87K	$129.0K	$7.874K
YoY Change	736.59%	180.53%	52.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.18K	$4.855K	$9.500K
YoY Change	17.69%	-69.56%	-13.4%
Accrued Expenses	$156.1K	$144.1K	$100.8K
YoY Change	54.82%	-87.17%	-89.18%
Deferred Revenue
YoY Change
Short-Term Debt	$95.00K	$320.0K	$120.0K
YoY Change	-20.85%	204.76%	166.73%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.650M	$1.842M	$1.579M
YoY Change	4.48%	31.35%	38.41%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.650M	$1.842M	$1.579M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.650M	$1.842M	$1.579M
YoY Change	4.48%	31.35%	38.41%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.745M	-$5.817M	-$5.302M
YoY Change	8.35%
Common Stock	$1.708K	$1.703K	$1.570K
YoY Change	8.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.584M	-$1.713M	-$1.571M
YoY Change
Total Liabilities & Shareholders Equity	$65.87K	$129.0K	$7.874K
YoY Change	736.59%	180.53%	52.01%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q4
OPERATING ACTIVITIES
Net Income	$72.58K	-$25.07K	-$357.4K
YoY Change	-120.31%	-88.84%	-38.11%
Depreciation, Depletion And Amortization	$0.00	$0.00	$300.00
YoY Change	-100.0%	-100.0%	0.0%
Cash From Operating Activities	-$10.15K	-$174.2K	-$56.20K
YoY Change	-81.94%	161.31%	110.64%
INVESTING ACTIVITIES
Capital Expenditures	$0.00		-$250.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$225.0K	$165.0K
YoY Change
Cash From Investing Activities	$225.0K	$165.0K	-$250.00
YoY Change	-90100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-268.9K	125.4K	15.24K
YoY Change	-1864.44%	18.11%	-48.74%
NET CHANGE
Cash From Operating Activities	-10.15K	-174.2K	-56.20K
Cash From Investing Activities	225.0K	165.0K	-250.0
Cash From Financing Activities	-268.9K	125.4K	15.24K
Net Change In Cash	-54.05K	116.1K	-41.21K
YoY Change	31.16%	194.27%	-1451.15%
FREE CASH FLOW
Cash From Operating Activities	-$10.15K	-$174.2K	-$56.20K
Capital Expenditures	$0.00		-$250.00
Free Cash Flow	-$10.15K		-$55.95K
YoY Change	-81.86%		109.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity File Number EntityFileNumber	333-238326
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3321759
	dei	Entity Address Address Line1 EntityAddressAddressLine1	548 Market Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 90355
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94104
	dei	Entity Address Address Description EntityAddressAddressDescription	Address of Principal Executive Office
	dei	City Area Code CityAreaCode	888
	dei	Local Phone Number LocalPhoneNumber	420-6856
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17051950	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	116114	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3780	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4974	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7620	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3750	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	128708	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	7530	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	94	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	250	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	250	usd
CY2022Q3	us-gaap	Assets Assets	128958	usd
CY2021Q4	us-gaap	Assets Assets	7874	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4855	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9500	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	338224	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	391067	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	899572	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	761463	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	144050	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	100796	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	46133	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	38070	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	45000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	45000	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	275000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	75030	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	88784	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	158191	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1841618	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1579117	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.190
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	295000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	295000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17027950	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17027950	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15694550	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15694550	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	1703	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1570	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4102918	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3729104	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5817281	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5301917	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-1712660	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1571243	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	128958	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7874	usd
CY2022Q3	fil	Net Revenues NetRevenues	4974	usd
CY2021Q3	fil	Net Revenues NetRevenues	149	usd
	fil	Net Revenues NetRevenues	7623	usd
	fil	Net Revenues NetRevenues	12045	usd
CY2022Q3	us-gaap	Revenues Revenues	4974	usd
CY2021Q3	us-gaap	Revenues Revenues	149	usd
	us-gaap	Revenues Revenues	7623	usd
	us-gaap	Revenues Revenues	12045	usd
CY2022Q3	fil	Cost Of Revenues Net CostOfRevenuesNet	2487	usd
CY2021Q3	fil	Cost Of Revenues Net CostOfRevenuesNet	0	usd
	fil	Cost Of Revenues Net CostOfRevenuesNet	2487	usd
	fil	Cost Of Revenues Net CostOfRevenuesNet	8000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	2487	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2487	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	2487	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	149	usd
	us-gaap	Gross Profit GrossProfit	5136	usd
	us-gaap	Gross Profit GrossProfit	4045	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	103636	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	130337	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	317550	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	316308	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	73294	usd
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	118004	usd
	us-gaap	Professional Fees ProfessionalFees	327087	usd
	us-gaap	Professional Fees ProfessionalFees	309440	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	294	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	94	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	883	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	176930	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	248635	usd
	us-gaap	Operating Expenses OperatingExpenses	644731	usd
	us-gaap	Operating Expenses OperatingExpenses	626631	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-174443	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-248486	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-639595	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-622586	usd
CY2022Q3	fil	Recovery Of Expense In Litigation RecoveryOfExpenseInLitigation	0	usd
CY2021Q3	fil	Recovery Of Expense In Litigation RecoveryOfExpenseInLitigation	22382	usd
	fil	Recovery Of Expense In Litigation RecoveryOfExpenseInLitigation	0	usd
	fil	Recovery Of Expense In Litigation RecoveryOfExpenseInLitigation	22382	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	14220	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	14220	usd
CY2022Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	165000	usd
CY2021Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	165000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	15625	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	12837	usd
	us-gaap	Interest Expense InterestExpense	40769	usd
	us-gaap	Interest Expense InterestExpense	32229	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	149375	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23765	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	124231	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4373	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-25068	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-224721	usd
	us-gaap	Net Income Loss NetIncomeLoss	-515364	usd
	us-gaap	Net Income Loss NetIncomeLoss	-618213	usd
CY2022Q3	fil	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare	-0.00
CY2021Q3	fil	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare	-0.01
	fil	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare	-0.03
	fil	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare	-0.04
CY2022Q3	fil	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	16803061	shares
CY2021Q3	fil	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	15337287	shares
	fil	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	16147094	shares
	fil	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	15032325	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1571243	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	35105	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	69412	usd
CY2022Q1	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	25500	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-234217	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-1675443	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	24310	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	120170	usd
CY2022Q2	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	25500	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-256079	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1761542	usd
CY2022Q3	fil	Common Stock Issued For Restricted Stock Awards CommonStockIssuedForRestrictedStockAwards	0	usd
CY2022Q3	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	73950	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-25068	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-1712660	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1135712	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	6000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	29868	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-137325	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-1237169	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	25000	usd
CY2021Q2	fil	Common Stock Issued For Anti Dilution Protection CommonStockIssuedForAntiDilutionProtection	0	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	120713	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-256167	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-1347623	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	96500	usd
CY2021Q3	fil	Common Stock Issued For Restricted Stock Awards CommonStockIssuedForRestrictedStockAwards	0	usd
CY2021Q3	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	25500	usd
CY2021Q3	fil	Common Stock Issued For Settlement Of Liabilities CommonStockIssuedForSettlementOfLiabilities	15780	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	78487	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-224721	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-1356077	usd
	us-gaap	Net Income Loss NetIncomeLoss	-515364	usd
	us-gaap	Net Income Loss NetIncomeLoss	-618213	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	94	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	883	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	189582	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	229068	usd
	fil	Common Stock Issued For Settlement Of Liabilities CommonStockIssuedForSettlementOfLiabilities	0	usd
	fil	Common Stock Issued For Settlement Of Liabilities CommonStockIssuedForSettlementOfLiabilities	15780	usd
	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	124950	usd
	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	25500	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	165000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4974	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3870	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	583	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4645	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4981	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-52843	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	31361	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	138109	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	138106	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	43254	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	15089	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-3000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	8063	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	6996	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-242644	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-154032	usd
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	165000	usd
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	165000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	59415	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	127500	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	232620	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	60000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	32650	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	31546	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	69407	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	23926	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	189978	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	195120	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	112334	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	41088	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3780	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3906	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	116114	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44994	usd
	us-gaap	Interest Paid InterestPaid	1253	usd
	us-gaap	Interest Paid InterestPaid	1937	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font:11pt Times New Roman;margin:0;margin-right:-1.8pt"><b>NOTE 1 – ORGANIZATION AND OPERATIONS</b></p> <p style="font:11pt Times New Roman;margin:0;margin-right:-1.8pt"> </p> <p style="font:11pt Times New Roman;margin:0;text-indent:36pt"><b><i>Organization</i></b></p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">The Company was incorporated in June 2013 as Somerset Transition Corporation under the Oklahoma General Corporation Act. The Company was formed to complete a reorganization under Section 1088(g) of the Oklahoma Act, whereby the Company became successor to Transnational Financial Network, Inc., which was originally incorporated in California in 1985. In September 2013, the Company was redomesticated in Maryland and changed its name to Somerset Property, Inc. In July 2017, the Company was redomesticated in Nevada and changed its name to Revival, Inc. In June 2019, the Company changed its name to Farmhouse, Inc. to reflect its new business endeavors. </p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">In August 2019, the Company acquired Farmhouse, Inc., a Washington corporation (“Farmhouse Washington”) as its wholly owned subsidiary (the “Acquisition”). Farmhouse Washington was formed in January 2014 and has developed a social network platform, “The WeedClub® Platform”. At the closing of the Acquisition, all of the issued and outstanding shares of common stock of Farmhouse Washington were exchanged for shares of common stock of the Company on a one-for-one basis. The financial statements of the Company are the continuation of Farmhouse Washington with the adjustment to reflect the capital structure of the Company. </p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">Prior to the Acquisition, in August 2017, Farmhouse Washington formed Farmhouse DTLA, Inc. (“DTLA”) in California as a wholly owned subsidiary. In April 2021, DTLA was awarded a 49% equity interest in a Los Angeles based multi-licensed cannabis retail dispensary, grow, manufacturer and distributor called Los Angeles Farmers, Inc. (“LAFI”). Although ownership percentages over 20% would typically be accounted for using the equity method, the Company is accounting for this investment as an investment in equity securities due to the Company not having significant influence over LAFI. The cost of this investment was expensed during the fiscal year ended December 31, 2017 and, due to uncertainties surrounding the value of LAFI and determining any award of back profits and interest, as well as the pending litigation, no value has been reflected in our unaudited interim condensed consolidated financial statements as of September 30, 2022. See Note 9.</p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0;text-indent:36pt"><b><i>Current Operations</i></b></p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">The Company is a technology company with multiple cannabis related divisions and IP, including the WeedClub® Platform, <span style="background-color:#FFFFFF">the @420 Twitter handle and a Web3 division.</span> <span style="background-color:#FFFFFF">The </span>WeedClub® Platform<span style="background-color:#FFFFFF"> is a cannabis social network platform that enables industry professionals to connect, discover products and services and scale their businesses. </span>Within the WeedClub® Platform, members utilize an increasing set of technology-based tools for discovering professional connections and information. <span style="background-color:#FFFFFF">The Company’s @420 Twitter handle sits at the intersection of cannabis and Web3 communities and serves as a public platform to connect with cannabis enthusiasts.</span> <span style="background-color:#FFFFFF">The Company’s Web3 division, launched in December 2021, connects the cannabis and NFT industries through NFT licensing, artist partnerships, and generative projects.</span></p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0;text-indent:36pt"><b><i>Going Concern and Management’s Plans</i></b></p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">The accompanying unaudited interim condensed consolidated financial statements have been presented on the basis that the Company is a going concern which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. For the nine months ended September 30, 2022, </p> <p style="font:11pt Times New Roman;margin:0">the Company had a net loss from operations of $639,595, consisting primarily of general and administrative and legal and professional expenses. In addition, as of September 30, 2022, the Company had stockholders’ deficit of $1,712,660. In view of these matters, recoverability of any asset amounts shown in the accompanying unaudited interim condensed consolidated financial statements is dependent upon the Company’s ability to expand operations and achieve profitability from its business. These factors raise substantial doubt about the Company’s ability to continue as a going concern. These unaudited interim condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">The Company has financed its activities principally from the sale of its common stock and loans from Company officers. The Company intends on financing its future working capital needs from these sources until such time that funds provided by operations are sufficient to fund working capital requirements. Management believes that loans from Company officers and funds raised from the sale of its common stock will allow sufficient capital for operations and to continue as a going concern.</p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">In February 2022, the board of directors (“Board”) authorized an offering of up to 294,118 shares of restricted common stock at $0.85 per share, providing proceeds of up to $250,000, to be offered and sold only to investors that qualify as “accredited investors” as that term is defined in Regulation D. For the nine months ended September 30, 2022, the Company sold 69,900 shares of common stock under this offering for proceeds of $59,415. The offering expired on August 1, 2022. See Note 7.</p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">In June 2022, the Company received an unsolicited offer for $165,000, net of commission, for its domain name “blunt.com” from an unaffiliated party. Management considered this offer to be a fair arms-length price for a premium domain name and in July 2022, the Company sold the domain name. This was recorded as other income for the three and nine months ended September 30, 2022. See Note 12.</p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">In June 2022, the Company executed a Litigation Funding Agreement with Legalist Fund III, LP (“Legalist”), whereby Legalist provided $225,000 of funding under a Litigation Funding Agreement. See Notes 5 and 9. </p>
	us-gaap	Operating Income Loss OperatingIncomeLoss	-639595	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-1712660	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	330000	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font:11pt Times New Roman;margin:0;text-indent:36pt"><b><i>Financial Statement Reclassification</i></b></p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">Certain amounts from the prior year’s financial statements have been reclassified in these unaudited interim condensed consolidated financial statements to conform to the current year’s classifications.</p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font:11pt Times New Roman;margin:0;text-indent:36pt"><b><i>Use of Estimates</i></b></p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0;color:#000000">Operating results for interim periods are not necessarily indicative of the results to be expected for the full year. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Significant estimates include the carrying value of property and equipment and intangible assets, grant date fair value of options, deferred tax assets and any related valuation allowance and related disclosure of contingent assets and liabilities. The Company evaluates its estimates, based on historical experience and on various other assumptions that it believes to be reasonable under the circumstances. Actual results could materially differ from these estimates.</p>
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	94	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	usd
CY2022Q3	us-gaap	Revenues Revenues	4974	usd
CY2021Q3	us-gaap	Revenues Revenues	149	usd
	us-gaap	Revenues Revenues	7623	usd
	us-gaap	Revenues Revenues	12045	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	45000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.264
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	45000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	45000	usd
CY2022Q3	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	7312	usd
CY2021Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	7312	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7312	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7218	usd
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	295	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	94	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	883	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	275000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	75030	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	32650	usd
	us-gaap	Interest Paid InterestPaid	1253	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	88784	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	158191	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	69407	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	23926	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	295000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	295000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	59415	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	189582	usd
CY2022Q3	fil	Common Stock Issued For Restricted Stock Awards Shares CommonStockIssuedForRestrictedStockAwardsShares	1070000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17027950	shares
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	6000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	229068	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	121500	usd
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15618050	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	150000	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.020
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Number Of Shares Period Increase Decrease SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease	-1070000	shares
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	890000	shares
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.260
CY2022Q3	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	73950	usd
	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	124950	usd
CY2021Q3	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	25500	usd
	fil	Stock Based Compensation On Rsa S Vested StockBasedCompensationOnRsaSVested	25500	usd
CY2022Q3	fil	Unrecognized Stock Based Compensation Expense On The Rsa Shares UnrecognizedStockBasedCompensationExpenseOnTheRsaShares	231350	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	88784	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	158191	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	165000	usd

Files In Submission

Name	View Source	Status
0001096906-22-002757-index-headers.html	Edgar Link	pending
0001096906-22-002757-index.html	Edgar Link	pending
0001096906-22-002757.txt	Edgar Link	pending
0001096906-22-002757-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fmhs-20220930.htm	Edgar Link	pending
fmhs-20220930.xsd	Edgar Link	pending
fmhs_ex31z1.htm	Edgar Link	pending
fmhs_ex31z2.htm	Edgar Link	pending
fmhs_ex32z1.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
fmhs-20220930_def.xml	Edgar Link	unprocessable
fmhs-20220930_lab.xml	Edgar Link	unprocessable
fmhs-20220930_pre.xml	Edgar Link	unprocessable
fmhs-20220930_cal.xml	Edgar Link	unprocessable
fmhs-20220930_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FMHS
FARMHOUSE, INC. /NV Stock $fmhs

2022 Q4 Form 10-Q Financial Statement

#000109690622002757 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FMHS FARMHOUSE, INC. /NV Stock $fmhs

2022 Q4 Form 10-Q Financial Statement

#000109690622002757 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FMHS
FARMHOUSE, INC. /NV Stock $fmhs